90 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... #Parenteral #IV ... Osteomyelitis #management ... #pharmacology #idsa
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... Prevention #Treatment #management ... #opportunistic
Treatment Checklist for Abdominal Compartment Syndrome

- Dr. Josh Farkas @PulmCrit

#Abdominal #Compartment #Syndrome #Checklist #Treatment #Management #CriticalCare
Abdominal Compartment Syndrome ... #Compartment #Syndrome ... Checklist #Treatment #Management ... #CriticalCare
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... Prevention #Treatment #management ... #opportunistic
ARDS - Overview

M. Daniyal Hashmi, MD @MDaniyalHashmi1

#ARDS #Respiratory #Distress #Acute #Syndrome #Diagnosis #Management #CriticalCare #summary
Distress #Acute #Syndrome ... #Diagnosis #Management ... #CriticalCare #
Useful Intravenous Antihypertensive Agents
- Nicardipine
- Clevidipine
- Labetalol
- Esmolol
- Nitroglycerin

Dr. Josh Farkas https://twitter.com/PulmCrit

#Antihypertensive #Agents #Hypertensive #Emergency #Pharmacology
#Intravenous #IV ... #CriticalCare # ... BloodPressure #Management
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Prevention #Treatment #management ... #opportunistic
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... Prevention #Treatment #management ... #opportunistic